Re-expansion pulmonary oedema (RPE) is an uncommon complication that occurs when a collapsed lung suddenly re-expands, resulting in an osmotic shift of fluid from the blood vessels into the air spaces ...

Medications for pulmonary embolism may decrease the size of blood clots, help dissolve them, or reduce the risk of recurrence. All of these medications carry the risk of bleeding. A pulmonary ...

Findings from the first international randomized controlled trial to compare patient outcomes following treatment with ...

(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.

Shatti, head of the Cardiac Catheterization Unit at Al-Dabous Center at Al-Adan Hospital, announced that the hospital has ...

The trial adds much-needed randomized data to an area where it’s been lacking. Questions about methods muddy interpretation.

Over the past century, heart operations that once were unthinkable have become commonplace. Thousands of times a day, ...

Jupiter Endovascular, Inc. announced that the first patient has been treated in the SPIRARE II United States pivotal study of ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

The FlowTriever system is 510(k)-Cleared by FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium. Inari Medical NewsMORE Related Stocks ...